Gayle Barbara Duncan

Affiliations

  • Director at Jounce Therapeutics Inc. (JNCE), 2021-06-22
  • Director at Atea Pharmaceuticals Inc. (AVIR), 2021-06-21
  • Director at Ovid Therapeutics Inc. (OVID), 2021-06-12
  • Director at Fusion Pharmaceuticals Inc. (FUSN), 2021-06-07
  • Director at Immunomedics Inc (IMMU), 2020-10-23
  • Director at Adaptimmune Therapeutics Plc (ADAP), 2020-07-01
  • Director at Aevi Genomic Medicine Inc. (GNMX), 2020-02-05
  • Director at Innoviva Inc. (INVA), 2017-04-24
  • Chief Accounting Officer at Intercept Pharmaceuticals Inc (ICPT), 2016-10-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GNMX $1.26 59,524 Director 59,524 2017-10-17 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
JNCE $10.50 5,000 Director 0 2020-09-15 Filing
JNCE $9.50 5,000 Director 5,000 2020-09-15 Filing
JNCE $28.11 2,000 Director 0 2018-03-15 Filing
JNCE $25.00 4,000 Director 0 2018-01-26 Filing
ICPT $163.20 147 Officer 30,661 2016-10-03 Filing